1. Home
  2. LGHL vs SCNI Comparison

LGHL vs SCNI Comparison

Compare LGHL & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGHL
  • SCNI
  • Stock Information
  • Founded
  • LGHL 2015
  • SCNI 2003
  • Country
  • LGHL Singapore
  • SCNI Israel
  • Employees
  • LGHL N/A
  • SCNI N/A
  • Industry
  • LGHL Investment Bankers/Brokers/Service
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LGHL Finance
  • SCNI Health Care
  • Exchange
  • LGHL Nasdaq
  • SCNI Nasdaq
  • Market Cap
  • LGHL 1.8M
  • SCNI 2.0M
  • IPO Year
  • LGHL N/A
  • SCNI N/A
  • Fundamental
  • Price
  • LGHL $2.29
  • SCNI $1.52
  • Analyst Decision
  • LGHL
  • SCNI
  • Analyst Count
  • LGHL 0
  • SCNI 0
  • Target Price
  • LGHL N/A
  • SCNI N/A
  • AVG Volume (30 Days)
  • LGHL 307.2K
  • SCNI 3.0M
  • Earning Date
  • LGHL 08-19-2025
  • SCNI 08-19-2025
  • Dividend Yield
  • LGHL N/A
  • SCNI N/A
  • EPS Growth
  • LGHL N/A
  • SCNI N/A
  • EPS
  • LGHL N/A
  • SCNI N/A
  • Revenue
  • LGHL N/A
  • SCNI $658,000.00
  • Revenue This Year
  • LGHL N/A
  • SCNI N/A
  • Revenue Next Year
  • LGHL N/A
  • SCNI N/A
  • P/E Ratio
  • LGHL N/A
  • SCNI N/A
  • Revenue Growth
  • LGHL N/A
  • SCNI N/A
  • 52 Week Low
  • LGHL $2.13
  • SCNI $1.40
  • 52 Week High
  • LGHL $20.86
  • SCNI $6.18
  • Technical
  • Relative Strength Index (RSI)
  • LGHL 39.44
  • SCNI 29.96
  • Support Level
  • LGHL $2.18
  • SCNI $1.40
  • Resistance Level
  • LGHL $2.48
  • SCNI $1.64
  • Average True Range (ATR)
  • LGHL 0.31
  • SCNI 0.24
  • MACD
  • LGHL -0.08
  • SCNI -0.03
  • Stochastic Oscillator
  • LGHL 10.60
  • SCNI 5.77

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: